2012 Speakers



Bonnie J. Addario

Bonnie J. Addario
Founder & Chair, President, The Bonnie J. Addario Lung Cancer Foundation

Margaret  Anderson

Margaret Anderson
Executive Director, FasterCures

Cecilia  Arradaza

Cecilia Arradaza
Director, Communications & Marketing, FasterCures

Christopher P. Austin

Christopher P. Austin
Director, National Center for Advancing Translational Sciences


Dana  Ball

Dana Ball
CEO and Co-Founder, T1D Exchange

Anna  Barker

Anna Barker
Director, Transformative Healthcare Networks, Co-Director, Complex Adaptive Systems Initiative and Professor, School of Life Sciences, Arizona State University

Louis  Berneman

Louis Berneman
Founding Partner, Osage University Partners

Jodi  Black

Jodi Black
Deputy Director, Division of Extramural Research Activities, National Heart Lung and Blood Institute, National Institutes of Health

Marc  Bonnefoi

Marc Bonnefoi
Head, North America R&D Hub, Sanofi US


Robert  Califf

Robert Califf
Professor of Cardiology, Vice Chancellor for Clinical Research, and Director of the Duke Translational Medicine Institute, Duke University School of Medicine

John  Chaffins

John Chaffins
Director, Product Design & Construction, Lybba

William  Chin

William Chin
Executive Dean for Research, Harvard Medical School

Chris  Coburn

Chris Coburn
Executive Director, Cleveland Clinic Innovations

N. Anthony   Coles

N. Anthony Coles
President, CEO, and Member of the Board, Onyx Pharmaceuticals

Richard  Colletti

Richard Colletti
Professor of Pediatrics and Vice Chair, Department of Pediatrics, University of Vermont School of Medicine

Francis  Collins

Francis Collins
Director, National Institutes of Health

Carolyn  Compton

Carolyn Compton
President and CEO, Critical Path Institute

Ceci  Connolly

Ceci Connolly
Managing Director, Health Research Institute, PricewaterhouseCoopers


Brett  Davis

Brett Davis
Senior Director, Health Sciences, Global Business Development and Strategy, Oracle

Kenneth  Davis

Kenneth Davis
President and CEO, The Mount Sinai Medical Center

Lou  DeGennaro

Lou DeGennaro
Chief Mission Officer, Leukemia and Lymphoma Society

Joseph  DeGeorge

Joseph DeGeorge
Vice President, Safety Assessment & Laboratory Animal Resources, Merck Research Laboratories

Susan  Dentzer

Susan Dentzer
Editor-in-Chief, Health Affairs

Joseph  DeSimone

Joseph DeSimone
Director, Frank Hawkins Kenan Institute of Private Enterprise, and Professor of Chemistry, University of North Carolina

Mikael  Dolsten

Mikael Dolsten
President, Worldwide Research and Development, Pfizer

Frank L. Douglas

Frank L. Douglas
President and CEO, Austen BioInnovation Institute


Jens  Eckstein

Jens Eckstein
President, SR One

Dale  Edgar

Dale Edgar
Vice President, Science and Technology Partnerships, Lilly Research Laboratories


Jon  Fredrickson

Jon Fredrickson
Vice President, Government Practice, Innocentive

Maria  Freire

Maria Freire
President, Foundation for the NIH

Stephen  Friend

Stephen Friend
President, Sage Bionetworks


Kathy  Giusti

Kathy Giusti
Founder and CEO, Multiple Myeloma Research Foundation

Scott  Gottlieb

Scott Gottlieb
Resident Fellow, American Enterprise Institute

Alberto  Gutierrez

Alberto Gutierrez
Director, Office of In Vitro Diagnostics and Radiological Health, Center for Devices and Radiological Health, Food and Drug Administration


Dan  Hartman

Dan Hartman
Director, Integrated Development, Bill and Melinda Gates Foundation

Matthew  Herper

Matthew Herper
Senior Editor, Forbes Magazine

Clifford A. Hudis

Clifford A. Hudis
Chief, Breast Cancer Medicine Service, Memorial Sloan-Kettering Cancer Center; President-elect, American Society of Clinical Oncology


Richard A. Insel

Richard A. Insel
Chief Scientific Officer, JDRF

Thomas  R.  Insel

Thomas R. Insel
Director, National Institute of Mental Health, National Institutes of Health

Elizabeth  Iorns

Elizabeth Iorns
Co-Founder and CEO, Science Exchange


Cheryl  Jaeger

Cheryl Jaeger
Senior Policy Advisor, Majority House Leadership, U.S. House of Representatives

Gautam   Jaggi

Gautam Jaggi
Global Lead Analyst/Editor of Beyond Borders and Progressions, Ernst & Young Global Life Sciences Center

Scott   Johnson

Scott Johnson
President, CEO, and Founder, Myelin Repair Foundation

Stephen  Johnson

Stephen Johnson
Partner, Kirkland & Ellis LLP


Regis B. Kelly

Regis B. Kelly
Director, The California Institute for Quantitative Biosciences (QB3), University of California


Risa  Lavizzo-Mourey

Risa Lavizzo-Mourey
President and CEO, Robert Wood Johnson Foundation

Jonathan  Leff

Jonathan Leff
Managing Director, Warburg Pincus

Lawrence J. Lesko

Lawrence J. Lesko
Professor of Pharmaceutics, Director, Center for Pharmacometrics and Systems Pharmacology, University of Florida

Freda  Lewis-Hall

Freda Lewis-Hall
Executive Vice President, Chief Medical Officer, Pfizer Inc.

Shari  Ling

Shari Ling
Deputy Chief Medical Officer, Centers for Medicare & Medicaid Services


Anmol  Madan

Anmol Madan
Co-founder, CEO, and Data Scientist, Ginger.io

Brian  Mansfield

Brian Mansfield
Deputy Chief Research Officer, Foundation Fighting Blindness

Peter  Margolis

Peter Margolis
Professor of Pediatrics and Director of Research, James M. Anderson Center for Health Systems Excellence, Cincinnati Children's Hospital Medical Center, University of Cincinnati School of Medicine

Michael  Milken

Michael Milken
Chairman, Milken Institute; Founder, FasterCures

Bernard  Munos

Bernard Munos
Chief Apostle, Breakthrough Innovation, InnoThink


Garry  Neil

Garry Neil
Partner, Apple Tree Partners


Sally  Okun

Sally Okun
Health Data Integrity Manager, PatientsLikeMe


Dominique  Pahud

Dominique Pahud
Director, Advancing Innovation, Ewing Marion Kauffman Foundation

Stelios   Papadopoulos

Stelios Papadopoulos
Co-Founder and Chairman, Exelixis

David  Parkinson

David Parkinson
Venture Partner, New Enterprise Associates

Steven  Marc  Paul

Steven Marc Paul
Director, Helen & Robert Appel Institute for Alzheimer's Research, Weill Cornell Medical College

Michael  Pellini

Michael Pellini
President and CEO, Foundation Medicine

Eric D. Perakslis

Eric D. Perakslis
Chief Information Officer and Chief Scientist (Informatics), U.S. Food and Drug Administration

Kim J. Popovits

Kim J. Popovits
President and CEO, Genomic Health, Inc.

Wendell  Primus

Wendell Primus
Senior Health Policy Advisor, Minority House Leadership, U.S. House of Representatives


Teresa Stanek Rea

Teresa Stanek Rea
Deputy Director, U.S. Patent and Trademark Office


Tomasz  Sablinski

Tomasz Sablinski
Founder, Transparency Life Sciences; Head of Development, Celtic Therapeutics

Jay   Schnitzer

Jay Schnitzer
Director, Defense Sciences Office, Defense Advanced Research Projects Agency (DARPA)

Wendy  Selig

Wendy Selig
President and CEO, Melanoma Research Alliance

Vicki  Seyfert-Margolis

Vicki Seyfert-Margolis
Senior Advisor, Science Innovation and Policy, Office of the Commissioner, U.S. Food and Drug Administration

Ben  Shapiro

Ben Shapiro
Senior Partner and Chair, PureTech Ventures

Todd  Sherer

Todd Sherer
CEO, The Michael J. Fox Foundation for Parkinson's Research

Greg  Simon

Greg Simon
CEO, Poliwogg

Susan  Solomon

Susan Solomon
CEO and Co-Founder, New York Stem Cell Foundation

Garen  Staglin

Garen Staglin
Co-founder, One Mind for Research

Melissa  Stevens

Melissa Stevens
Deputy Executive Director, FasterCures


Neera  Tanden

Neera Tanden
President and CEO, Center for American Progress; Counselor, Center for American Progress Action Fund

Russell  Teagarden

Russell Teagarden
Former Vice President, Scientific Affairs, Advanced Clinical Science & Research, Medco Health Solutions, Inc.

Steven  Tregay

Steven Tregay
Founder, President, and CEO, FORMA Therapeutics

Jeffrey  Trent

Jeffrey Trent
President and Research Director, The Translational Genomics Research Institute

Sean  Tunis

Sean Tunis
President and CEO, Center for Medical Technology Policy

Mark  Tykocinski

Mark Tykocinski
Dean, Jefferson Medical College


Robert  Urban

Robert Urban
Head, Cambridge Innovation Center, Johnson & Johnson

Dennis  Urbaniak

Dennis Urbaniak
Vice President, U.S. Diabetes, Sanofi


Chris  Varma

Chris Varma
President and CEO, Blueprint Medicines

Matthias  von Herrath

Matthias von Herrath
Director, Type 1 Diabetes Research and Development (R&D) Center, Novo Nordisk

George  Vradenburg

George Vradenburg
Chairman, USAgainstAlzheimer's


John  Wilbanks

John Wilbanks
Senior Fellow, Ewing Marion Kauffman Foundation

Alastair J.J. Wood

Alastair J.J. Wood
Partner, Symphony Capital

Janet   Woodcock

Janet Woodcock
Director, Center for Drug Evaluation and Research, U.S. Food and Drug Administration